Lupin trades higher on the BSE [Healthcare]
AI Summary1 min read
TL;DR
Lupin's stock price increased on the Bombay Stock Exchange. The company is a major global pharmaceutical firm based in India, known for its diverse product range and strong market presence in key therapeutic areas.
Tags
Pharmaceuticals & DrugsHealthcareLupinBSEpharmaceuticalstock markethealthcare
Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in many markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health.